TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019

B Dewidar, C Meyer, S Dooley, N Meindl-Beinker - Cells, 2019 - mdpi.com
Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and
hepatocellular carcinoma. To date, there is no direct approved antifibrotic therapy, and …

Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies

I Lurje, NT Gaisa, R Weiskirchen, F Tacke - Molecular Aspects of Medicine, 2023 - Elsevier
Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological
wound healing response and can occur in various organs such as the heart, lung, liver …

From NAFLD to MAFLD: implications of a premature change in terminology

ZM Younossi, ME Rinella, AJ Sanyal, SA Harrison… - …, 2021 - Wiley Online Library
Despite the substantial gains in our understanding of NAFLD/NASH over the past 2
decades, there has been some dissatisfaction with the terminology “non‐alcoholic” which …

[HTML][HTML] Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

CY Zhang, WG Yuan, P He, JH Lei… - World journal of …, 2016 - ncbi.nlm.nih.gov
Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity,
and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to …

[HTML][HTML] Liver fibrosis

MM Aydın, KC Akçalı - The Turkish Journal of Gastroenterology, 2018 - ncbi.nlm.nih.gov
Liver fibrosis is a wound-healing response generated against an insult to the liver that
causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may …

Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway

X Rong, J Liu, X Yao, T Jiang, Y Wang, F Xie - Stem cell research & …, 2019 - Springer
Abstract Background Mesenchymal stem cells (MSCs) are increasingly being applied as a
therapy for liver fibrosis. Exosomes possess similar functions to their parent cells; however …

The endothelium as a driver of liver fibrosis and regeneration

E Lafoz, M Ruart, A Anton, A Oncins, V Hernández-Gea - Cells, 2020 - mdpi.com
Liver fibrosis is a common feature of sustained liver injury and represents a major public
health problem worldwide. Fibrosis is an active research field and discoveries in the last …

Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications

TH Gao, W Liao, LT Lin, ZP Zhu, MG Lu, CM Fu, T Xie - Phytomedicine, 2022 - Elsevier
Background Hepatobiliary disease currently serves as an urgent health issue in public due
to health-modulating factors such as extension of life expectancy, increasingly sedentary …

Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways

R Wang, F Song, S Li, B Wu, Y Gu… - … design, development and …, 2019 - Taylor & Francis
Background: Liver fibrosis occurs due to chronic liver disease due to multiple
pathophysiological causes. The main causes for this condition are chronic alcohol abuse …

[PDF][PDF] Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells

J Zhang, Y Li, Q Liu, Y Huang, R Li, T Wu, Z Zhang… - …, 2021 - Wiley Online Library
Backgrounds and Aims Activation of hepatic stellate cells (HSCs) is a central driver of
fibrosis. This study aimed to elucidate the role of the deacetylase sirtuin 6 (Sirt6) in HSC …